ImmuCell Corporation Increase (Decrease) in Accounts Payable and Accrued Liabilities
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $472.70 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $618.67K, a 174.33% increase year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$145.97K.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$22.61K.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $133.04K.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$195.25K, a 153.85% decline from fiscal 2024.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $362.61K, a 130.97% increase from fiscal 2023.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $157.00K, a 54.04% decline from fiscal 2022.
- ImmuCell Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $341.61K, a 39.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $618.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $472.70K 10-Q · filed 2026-08-13 | $450.10K derived: sum of 3 quarters · filed 2026-08-13 | $583.13K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$145.97K 10-Q · filed 2026-05-14 | -$168.57K derived: sum of 2 quarters · filed 2026-05-14 | -$35.53K derived: sum of 3 quarters · filed 2026-05-14 | $189.98K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$22.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $110.43K derived: sum of 2 quarters · filed 2026-03-30 | $335.95K derived: sum of 3 quarters · filed 2026-08-13 | -$195.25K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $133.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $358.56K derived: sum of 2 quarters · filed 2026-08-13 | -$172.65K 10-Q · filed 2025-11-13 | -$197.04K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $225.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$305.68K 10-Q · filed 2026-08-13 | -$330.07K derived: sum of 3 quarters · filed 2026-08-13 | -$393.32K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$531.20K 10-Q · filed 2026-05-14 | -$555.59K derived: sum of 2 quarters · filed 2026-05-14 | -$618.84K derived: sum of 3 quarters · filed 2026-05-14 | -$188.58K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$24.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$87.63K derived: sum of 2 quarters · filed 2026-03-30 | $342.63K derived: sum of 3 quarters · filed 2026-03-30 | $362.61K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$63.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $367.01K derived: sum of 2 quarters · filed 2025-11-13 | $387.00K 10-Q · filed 2025-11-13 | $639.48K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $430.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $450.24K 10-Q · filed 2025-08-14 | $702.73K derived: sum of 3 quarters · filed 2025-08-14 | $616.42K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $19.98K 10-Q · filed 2025-05-14 | $272.47K derived: sum of 2 quarters · filed 2025-05-14 | $186.16K derived: sum of 3 quarters · filed 2025-05-14 | $435.48K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $252.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $166.18K derived: sum of 2 quarters · filed 2025-03-28 | $415.50K derived: sum of 3 quarters · filed 2025-03-28 | $157.00K 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | -$86.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $163.01K derived: sum of 2 quarters · filed 2024-11-13 | -$95.49K 10-Q · filed 2024-11-13 | $226.77K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $249.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$9.18K 10-Q · filed 2024-08-13 | $313.08K derived: sum of 3 quarters · filed 2024-08-13 | $309.71K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$258.51K 10-Q · filed 2024-05-14 | $63.76K derived: sum of 2 quarters · filed 2024-05-14 | $60.38K derived: sum of 3 quarters · filed 2024-05-14 | $229.11K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $322.26K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $318.89K derived: sum of 2 quarters · filed 2024-04-01 | $487.62K derived: sum of 3 quarters · filed 2024-04-01 | $341.61K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$3.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $165.35K derived: sum of 2 quarters · filed 2023-11-13 | $19.35K 10-Q · filed 2023-11-13 | $386.85K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $168.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $22.73K 10-Q · filed 2023-08-10 | -$199.65K 10-Q · filed 2022-08-11 | $390.23K derived: sum of 3 quarters · filed 2023-08-10 | $540.23K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$146.00K 10-Q · filed 2023-05-11 | -$368.38K 10-Q · filed 2022-05-12 | $221.50K derived: sum of 2 quarters · filed 2023-05-11 | $371.50K derived: sum of 3 quarters · filed 2023-05-11 | $141.41K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $367.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $517.50K derived: sum of 2 quarters · filed 2023-03-29 | $287.41K derived: sum of 3 quarters · filed 2023-03-29 | $245.76K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $150.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | -$80.09K derived: sum of 2 quarters · filed 2022-11-21 | -$121.74K 10-Q · filed 2022-11-21 | $255.92K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2021-06-30 | -$230.09K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | -$271.74K 10-Q/A · filed 2022-11-21 | $105.92K derived: sum of 3 quarters · filed 2022-11-21 | -$7.81K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2021-03-31 | -$41.65K 10-Q/A · filed 2022-11-21 | $336.01K derived: sum of 2 quarters · filed 2022-11-21 | $222.28K derived: sum of 3 quarters · filed 2022-11-21 | $496.72K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2020-12-31 | $377.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $263.93K derived: sum of 2 quarters · filed 2022-03-30 | $538.38K derived: sum of 3 quarters · filed 2022-03-30 | $299.88K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$113.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $160.71K derived: sum of 2 quarters · filed 2021-11-15 | -$77.78K 10-Q · filed 2021-11-15 | $52.68K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $274.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $35.95K 10-Q · filed 2021-08-12 | $166.41K derived: sum of 3 quarters · filed 2021-08-12 | $227.70K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$238.49K 10-Q · filed 2021-05-13 | -$108.03K derived: sum of 2 quarters · filed 2021-05-13 | -$46.74K derived: sum of 3 quarters · filed 2021-05-13 | -$360.91K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $130.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $191.75K derived: sum of 2 quarters · filed 2021-03-30 | -$122.42K derived: sum of 3 quarters · filed 2021-03-30 | -$88.71K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $61.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$252.88K derived: sum of 2 quarters · filed 2020-11-12 | -$219.17K 10-Q · filed 2020-11-12 | -$80.46K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$314.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$280.46K 10-Q · filed 2020-08-12 | -$141.75K derived: sum of 3 quarters · filed 2020-08-12 | $99.12K derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $33.70K 10-Q · filed 2020-05-13 | $172.41K derived: sum of 2 quarters · filed 2020-05-13 | $413.28K derived: sum of 3 quarters · filed 2020-05-13 | $328.68K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $138.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $379.58K derived: sum of 2 quarters · filed 2020-03-27 | $294.97K derived: sum of 3 quarters · filed 2020-03-27 | $80.16K 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $240.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $156.26K derived: sum of 2 quarters · filed 2019-11-12 | -$58.55K 10-Q · filed 2019-11-12 | $127.83K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$84.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$299.42K 10-Q · filed 2019-08-12 | -$113.05K derived: sum of 3 quarters · filed 2019-08-12 | $139.82K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | -$214.81K 10-Q · filed 2019-05-13 | -$28.44K derived: sum of 2 quarters · filed 2019-05-13 | $224.43K derived: sum of 3 quarters · filed 2019-05-13 | $101.99K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $186.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $439.24K derived: sum of 2 quarters · filed 2019-03-22 | $316.80K derived: sum of 3 quarters · filed 2019-03-22 | $448.64K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $252.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $130.43K derived: sum of 2 quarters · filed 2018-11-13 | $262.27K 10-Q · filed 2018-11-13 | $180.46K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$122.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $9.40K 10-Q · filed 2018-08-13 | $5.63K 10-Q · filed 2017-08-14 | -$72.41K derived: sum of 3 quarters · filed 2018-08-13 | $118.88K derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $131.84K 10-Q · filed 2018-05-14 | $128.07K 10-Q · filed 2017-05-11 | $50.03K derived: sum of 2 quarters · filed 2018-05-14 | $241.32K derived: sum of 3 quarters · filed 2018-05-14 | $218.03K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$81.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $109.48K derived: sum of 2 quarters · filed 2018-03-29 | $86.19K derived: sum of 3 quarters · filed 2018-03-29 | -$80.92K 10-K · filed 2018-03-29 | -$182.51K 10-K · filed 2017-03-30 | |||
| 2016-09-30 | $191.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $168.00K derived: sum of 2 quarters · filed 2017-11-13 | $891.00 10-Q · filed 2017-11-13 | -$100.70K 10-Q · filed 2016-11-10 | $153.58K derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | -$23.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$190.40K 10-Q · filed 2017-08-14 | -$37.71K derived: sum of 3 quarters · filed 2017-08-14 | $27.04K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$167.11K 10-Q · filed 2017-05-11 | -$14.42K derived: sum of 2 quarters · filed 2017-05-11 | $50.32K derived: sum of 3 quarters · filed 2017-05-11 | $6.15K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $152.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $217.44K derived: sum of 2 quarters · filed 2017-03-30 | $173.26K derived: sum of 3 quarters · filed 2017-03-30 | $60.36K 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $64.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $20.57K derived: sum of 2 quarters · filed 2016-11-10 | -$92.33K 10-Q · filed 2016-11-10 | $7.24K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | -$44.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$157.07K 10-Q · filed 2016-08-11 | -$57.51K derived: sum of 3 quarters · filed 2016-08-11 | -$159.44K derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | -$112.90K 10-Q · filed 2016-05-11 | -$13.34K derived: sum of 2 quarters · filed 2016-05-11 | -$115.26K derived: sum of 3 quarters · filed 2016-05-11 | $53.75K derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $99.57K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$2.36K derived: sum of 2 quarters · filed 2016-03-25 | $166.66K derived: sum of 3 quarters · filed 2016-03-25 | $178.56K 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$101.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $67.09K derived: sum of 2 quarters · filed 2015-11-12 | $78.99K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $169.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $180.92K 10-Q · filed 2015-08-13 | ||||||
| 2014-03-31 | $11.90K 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | -$57.99K 10-K · filed 2016-03-25 | |||||||
| 2012-12-31 | $51.72K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |